The robust links between LRRK2 and Parkinson’s disease have motivated the development of candidate therapeutic strategies designed to limit LRRK2 kinase activity and have raised important questions about the functions of LRRK2 and how they contribute to disease-causing cellular processes (5, –7). The gene discussed is LRRK2; the disease is Parkinson disease.